GGrantIndex
← Leaderboards

Heather Elspeth Moss

University Of Illinois At Chicago

$3,684,596
Attributed
$3,684,596
Total exposure
3
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $565.3K · FY201425
$1M$750K$500K$250K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,684,596 · 3

By mechanism

R01$2,132,927 · 1
K23$1,056,270 · 1
R21$495,399 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Illinois At Chicago

Same institution · by research overlap

Others in their field

Top investigators on “Optic Nerve

Research focus

Optic NerveBiological MarkersFunctional DisorderVisionBrainPhysiciansBlindnessVisualGlaucomaAffectRetinal Ganglion CellsImageProductivityLightScanningVisual PathwaysDiagnosisStructureResearch PersonnelMonitorCaringPerimetryClinical ResearchBase

Grant awards (13)

Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss$519,970
R01 · FY2025 · EY · contact PI
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss$519,970
R01 · FY2024 · EY · contact PI
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss$520,727
R01 · FY2023 · EY · contact PI
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss$44,600
R01 · FY2023 · EY · contact PI
Beyond ganglion cells: Novel foveal avascular zone features in MS with implications for vision loss$527,660
R01 · FY2022 · EY · contact PI
Retinal vessel features as a marker of idiopathic intracranial hypertension treatment response: a secondary analysis of the idiopathic intracranial hypertension treatment trial$194,136
R21 · FY2021 · EY · contact PI
Retinal vessel features as a marker of idiopathic intracranial hypertension treatment response: a secondary analysis of the idiopathic intracranial hypertension treatment trial$301,263
R21 · FY2020 · EY · contact PI
Physiologically Based Markers of Idiopathic Intracranial Hypertension$211,254
K23 · FY2018 · EY · contact PI
Physiologically Based Markers of Idiopathic Intracranial Hypertension$211,254
K23 · FY2017 · EY · contact PI
Physiologically Based Markers of Idiopathic Intracranial Hypertension$148,163
K23 · FY2016 · EY · contact PI
Physiologically Based Markers of Idiopathic Intracranial Hypertension$63,091
K23 · FY2016 · EY · contact PI
Physiologically Based Markers of Idiopathic Intracranial Hypertension$211,254
K23 · FY2015 · EY · contact PI
Physiologically Based Markers of Idiopathic Intracranial Hypertension$211,254
K23 · FY2014 · EY · contact PI